On the contrary, belimumab (a fully human anti B-cell activating factor (BAFF) mAb), which is used to treat systemic lupus erythematosus (SLE) patients, showed low rates induction ADA (74). The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.